Robert Glanzman - 16 May 2022 Form 4 Insider Report for Clene Inc. (CLNN)

Reporting relationship: Chief Medical Officer
Issuer ticker: CLNN
Reported as of: 16 May 2022
Net transaction value: -$9,576
SEC form: 4
Accepted by SEC: 18 May 2022, 08:34:58 UTC
Prior SEC filing: 16 Feb 2022
Source filing: View source filing
Reporting owner signature: /s/ Jerry Miraglia POA

Key filing fact

Robert Glanzman filed Form 4 for Clene Inc. (CLNN) on 18 May 2022.

Key facts

This page summarizes Robert Glanzman's Form 4 filing for Clene Inc. (CLNN).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 18 May 2022, 08:34.

Change

Previous filing in this sequence was filed on 16 Feb 2022.
Current net transaction value: -$9,576.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CLNN transaction

Common Stock

Sale

Transaction value: $9,576
Shares: -4,717
Change %: -31%
Price: $2.03
Shares after: 10,564
Date: 16 May 2022
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The sales reported in this Form 4 represent shares of common stock of Clene Inc. required to by sold by Mr. Glanzman to satisfy tax withholding obligations in connection with the vesting of restricted stock awards. The sale occurred automatically to satisfy the tax withholding obligation to be funded by a "sell to cover" transaction pursuant to a Rule 10b5-1 trading plan and does not represent a discretionary transaction by Mr. Glanzman.